Effect of liraglutide on inflammatory response of peripheral blood mononuclear cells (PBMCs) in subjects at risk of type 2 diabetes
2022/45/N/NZ7/03393
Keywords
Descriptors
- NZ7_012: Prewencja chorób człowieka
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Uniwersytet Medyczny w Białymstoku
Voivodeship: podlaskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 3
Call
PRELUDIUM 21 – announced on 2022-03-28
- Amount awarded
- 209 230 PLN
- Project start date
- 2023-02-01
- Project end date
- 2027-01-31
- Project duration
- 48 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.